Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
1996-11-29
2001-02-06
Salimi, Ali (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S204100, C424S186100, C424S194100, C424S229100, C424S230100, C435S235100, C435S320100, C435S070100, C530S350000, C530S300000, C536S023720
Reexamination Certificate
active
06183751
ABSTRACT:
Throughout this application, various publications may be referenced by Arabic numerals in brackets. Full citations for these publications may be found at the end of the Detailed Description of the Invention. The disclosures of all publications cited herein are in their entirety hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Kaposi's sarcoma-associated herpesvirus (KSHV) is a new human herpesvirus (HHV8) believed to cause Kaposi's sarcoma (KS) [1,2].
Kaposi's sarcoma is the most common neoplasm occurring in persons with acquired immunodeficiency syndrome (AIDS). Approximately 15-20% of AIDS patients develop this neoplasm which rarely occurs in immunocompetent individuals. Epidemiologic evidence suggests that AIDS-associated KS (AIDS-KS) has an infectious etiology. Gay and bisexual AIDS patients are approximately twenty times more likely than hemophiliac AIDS patients to develop KS, and KS may be associated with specific sexual practices among gay men with AIDS. KS is uncommon among adult AIDS patients infected through heterosexual or parenteral HIV transmission, or among pediatric AIDS patients infected through vertical HIV transmission. Agents previously suspected of causing KS include cytomegalovirus, hepatitis B virus, human papillomavirus, Epstein-Barr virus (EBV), human herpesvirus 6, human immunodeficiency virus (HIV), and Mycoplasma penetrans. Non-infectious environmental agents, such as nitrite inhalants, also have been proposed to play a role in KS tumorigenesis. Extensive investigations, however, have not demonstrated an etiologic association between any of these agents and AIDS-KS.
SUMMARY OF THE INVENTION
This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) polypeptides. This invention provides an isolated polypeptide molecule of KSHV. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposi's Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
REFERENCES:
patent: 5861240 (1999-01-01), Ganem et al.
Baer et al (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome, Nature 310, 207-211.
Mosca et al (1987) Herpes simplex virus type-1 can reactivate transcription of latent immunodeficiency virus, Nature 325, 67-70.
Delli Bovi et al (1987) Isolation of a rearranged human transforming gene following transfection of Kaposi sarcom DNA, Proc Natl Acad Sci USA 84, 5660-5664.
Gallo (1993) Aspects of the molecular pathogenesis of AIDS, J Cellular Biochem 17E, 5.
Gallo (1994) New approaches for interfering with human immunodeficiency virus replication and for Kaposi's sarcoma, J Cellular Biochem 18B, 108.
Chang et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma, Science 265, 1865-1869.
Cesarman et al (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas, The FASEB Journal 9, A973, Abstract 5650.
Gompels et al (1988) Conservation of glycoprotein H (gh) in herpes-viruses: nucleotide sequence of the gH gene from herpesvirus saimiri, J Gen Virol 69, 2819-2829.
Forrester et al (1991) Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted, J Virol 66, 341-348.
Roop et al (1993) A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein L cannot enter cells, and its particles lack glycoprotein H, J Virol 67, 2285-2297.
Scott et al (1993) Identification and sequence analysis of the homologues of the herpes simplex virus type 1 glycoprotein H in Marek's disease virus and the herpesvirus of turkeys, J Gen Virol 74, 1185-1190.
Liu et al (1993) Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies, Virology 197, 12-22.
Tewari et al (1994) Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model, J Gen Virol 75, 1735-1741.
McGowan et al (194) Expression and characterization of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus, Arch Virol 137, 389-395.
Pulford et al (1994) Expression of the Epstein-Barr virus envelope fusion glycoprotein gp85 gene by a recombinant baculovirus, J Gen Virol 75, 3241-3248.
Farrell et al (1994) Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deletd, J Virol 68, 927-932.
Baranowski et al (1995) Synthesis and processing of bovine herpesvirus-1 glycoprotein H, Virology 206, 651-654.
Ambroziak and Blackbourn (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma, Science 268, 582-583.
Bassett et (1995) Cancer in the African population of Harare, Zimbabwe, 1990-1992, Int J Canc 63, 29-36.
Benelli et al (1996) Isolation of spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage, Cancer Lett 100, 125-132.
Boshoff et al (1995) Kaposi's sarcoam-associated herpesvirus infects endothelial and spindle cells, Nat Med 1, 1274-1278.
Brady et al (1995) Altered cytokine expression in T lymphocytes from human immunodeficiency virus tat-transgenic mice, J Virol 69, 7622-7629.
Braun et al (1995) Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis, Mol Cell Biol 15, 4623-4630.
Broder and Karp (1995) Progress against cancer, J Cancer Res 121, 633-647.
Cesarman et al (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity base lymphomas, Faseb J 9, A973.
Cesarman et al (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas, New Eng J Med 332, 1186-1191.
Cesarman (1995) Periorbital edema in Kaposi's sarcoma, New Eng J Med 333, 799.
Cesarman et al (1995) In virtro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences, Blood 86, 2708-2714.
Chang (1995) Letter to the editor, Science 267, 1079.
Chang et al (1995) Letter to the editor, Annal Oncol 6, 744-745.
Chang et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma, Science 266, 1856-1869.
Chee et al (1990) Human cytomegalovirus encodes three G protein-coupled receptor homologues, Nature 344, 744-777.
Cohen (1994) Is a new virus the cuase of KS?, Science 266,1803-1804.
Cohen (1995) Controversy: is KS really caused by new herpesvirus, Science 268, 1847-1848.
Coleman et al (1995) Generalized endemic Kaposi's sarcoma, Clin Exp 20, 471-473.
Collandre et al (1995) Kaposi's sarcoma and new herpesvirus, Lancet 345, 1043.
Costagliola et al (1995) Can antiviral agents decrease the occurence of Kaposi's sarcoma!, Lancet 346, 578.
Delellis et al (1995) Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma, J Infec Dis 172, 1605-1607.
Drew and Brindley (1995) Female-specific sequences isolated from Schistosoma mansoni by representational difference analysis, Mol Biochem Parasitology 71, 173-181.
Dupin (1995) Letter to the editor, New Eng J Med 333, 798.
Duvic (1995) Human immunodeficiency virus and the skin: selected controversies, J Inves Derm 10, S117-S120.
Ekman (1995) Herpes virus like (KSHV) DNA in various forms of Kaposi's sarcoma (KS) and malignant lymphoma (ML), National Canc Inst 11, S74.
Farid (1995) Letter to the editor, New Eng J Med 332, 16
Bohenzky Roy A.
Chang Yuan
Edelman Isidore S.
Moore Patrick S.
Russo James J.
Cooper & Dunham LLP
Salimi Ali
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Unique associated Kaposi's Sarcoma virus sequences and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Unique associated Kaposi's Sarcoma virus sequences and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unique associated Kaposi's Sarcoma virus sequences and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2581400